WNT ligands induce Ca 2+ signalling on target cells. PKD1 (polycystin 1) is considered an orphan, atypical G-protein-coupled receptor complexed with TRPP2 (polycystin 2 or PKD2), a Ca 2+ -permeable ion channel. Inactivating mutations in their genes cause autosomal dominant polycystic kidney disease (ADPKD), one of the most common genetic diseases. Here, we show that WNTs bind to the extracellular domain of PKD1 and induce whole-cell currents and Ca 2+ influx dependent on TRPP2. Pathogenic PKD1 or PKD2 mutations that abrogate complex formation, compromise cell surface expression of PKD1, or reduce TRPP2 channel activity suppress activation by WNTs. Pkd2 −/− fibroblasts lack WNT-induced Ca 2+ currents and are unable to polarize during directed cell migration. In Xenopus embryos, pkd1, Dishevelled 2 (dvl2) and wnt9a act within the same pathway to preserve normal tubulogenesis. These data define PKD1 as a WNT (co)receptor and implicate defective WNT/Ca 2+ signalling as one of the causes of ADPKD.
WNT ligands induce Ca 2+ signalling on target cells. PKD1 (polycystin 1) is considered an orphan, atypical G-protein-coupled receptor complexed with TRPP2 (polycystin 2 or PKD2), a Ca 2+ -permeable ion channel. Inactivating mutations in their genes cause autosomal dominant polycystic kidney disease (ADPKD), one of the most common genetic diseases. Here, we show that WNTs bind to the extracellular domain of PKD1 and induce whole-cell currents and Ca 2+ influx dependent on TRPP2. Pathogenic PKD1 or PKD2 mutations that abrogate complex formation, compromise cell surface expression of PKD1, or reduce TRPP2 channel activity suppress activation by WNTs. Pkd2 −/− fibroblasts lack WNT-induced Ca 2+ currents and are unable to polarize during directed cell migration. In Xenopus embryos, pkd1, Dishevelled 2 (dvl2) and wnt9a act within the same pathway to preserve normal tubulogenesis. These data define PKD1 as a WNT (co)receptor and implicate defective WNT/Ca 2+ signalling as one of the causes of ADPKD.
The Wnt signalling pathway regulates essential biological functions [1] [2] [3] . It is divided into two major arms, the canonical Wnt/β-catenin pathway, and a β-catenin-independent pathway that is mainly responsible for establishing planar cell polarity (PCP) and tissue morphogenesis. Activation of the non-canonical pathway is often accompanied by a transient increase in intracellular Ca 2+ ([Ca 2+ ] i ) 4 . The pathway leading to this increase in [Ca 2+ ] i is poorly defined, but it seems to involve Ca 2+ release from intracellular stores downstream of the activation of Frizzled (FZD) [5] [6] [7] and RYK receptors 8 . There is also evidence for WNT-induced Ca 2+ influx, probably through transient receptor potential (TRP) or store-operated Ca 2+ channels 7, 9 . However, specific receptors and channels responsible for WNT-induced Ca 2+ influx are unknown.
In the mouse embryonic kidney, tubular diameter is controlled by WNT9B in a β-catenin-independent manner 10 . A similar mechanism seemed possible for PKD1 11, 12 , suggesting that WNT9B and PKD1 may function in the same pathway. PKD1 is a large protein of unknown function 13 ( Fig. 1a) . Its extracellular portion contains two leucine-rich repeats (LRRs) flanked by amino-and carboxy-terminal cysteine-rich domains (CRDs) followed by a cell-wall integrity and stress response component (WSC) domain. A second CRD showing weak homology to low-density lipoproteins (LDL-A domain) is located downstream 14 ( Fig. 1a) . These domains are unique to PKD1 and not present in homologous molecules such as PKD1L1-3. The C-terminal cytoplasmic tail of PKD1 interacts with multiple G protein α-subunits 15 and TRPP2 [16] [17] [18] . TRPP2 belongs to the TRP superfamily of ion channels and forms a Ca 2+ -permeable non-selective cation channel in association with PKD1 19, 20 or other TRP channels [20] [21] [22] [23] . The structure of PKD1 along with its ability to associate with TRPP2 has suggested that PKD1 and TRPP2 form a receptor/channel complex. However, the molecular identity of the ligand(s) of this complex and thus, its physiological mechanism of activation has been a mystery.
In this study, we identify secreted WNTs as activating ligands of the PKD1/TRPP2 complex. Activation of PKD1/TRPP2 by WNTs is independent of FZD receptors. We further show that TRPP2 is required for WNT9B-induced directed cell migration, a Ca 2+ -dependent process often used as a surrogate assay for morphogenetic cell movements (convergent extension) during kidney tubule elongation. Finally, we identify DVL2 as an interacting partner of PKD1 and show that wnt9a, pkd1 and dvl2 function in the same pathway to control Xenopus pronephric tubule formation.
RESULTS

WNT ligands can bind to the extracellular domain of PKD1
The cystic phenotype of Wnt9b-kidney null mice, along with the presence of several CRDs in PKD1 prompted us to test whether WNTs could physically interact with PKD1. Indeed, WNT9B co-immunoprecipitated with PKD1 but not with the structurally (h) 390 ng of purified LRR-WSC-Fc or Fc was incubated with 500 ng ml −1 purified WNT9B. Fc fusions were pulled down with protein G and immunocomplexes were blotted with anti-WNT9B. 87 ng of WNT9B bound to 390 ng of LRR-WSC-Fc (lane 1). 120, 60 and 30 ng of purified WNT9B were used as reference points. Experiments were successfully repeated two (b,d,f,g,h) or five (c,e) times. Unprocessed original scans of blots are shown in Supplementary Fig. 8 . similar PKD1L1 or TRPC1 (Fig. 1b) . Next, we tested whether WNT9B could associate with various fragments of the extracellular domain unique to PKD1 in the extracellular space. The CRD of FZD8 was used as a reference point, because its affinity to WNT9B is known (K d =482 ± 16 nM; ref. 24) . WNT9B associated with the LRR-WSC-Fc and LDL-A-Fc (Fig. 1c) . LRR-WSC-Fc also associated with WNT9B in the extracellular space in trans, whereby cells were singly transfected with Fc constructs or WNT9B, co-cultured for 24 h, and protein-protein interactions were detected in the cultured media (Fig. 1d ). PKD1 interacted with WNT9B through a site that included the C-terminal CRD of the LRR and the WSC domain (LRR-CT+WSC-Fc, Fig. 1e ). To test whether PKD1 and WNT9B interacted directly, we purified LRR-WSC-Fc from conditioned media of stably transfected HEK293 cells and incubated it with purified WNT9B. Eighty-seven nanograms (or 2.35 pmol) of purified WNT9B was pulled down with 390 ng (or 5.2 pmol) of purified PKD1-Fc fusion (Fig. 1f-h ). Under the same conditions, full-length TRPP2-Myc isolated from total cell lysates did not interact with purified WNT9B (Supplementary Fig. 1g ).
WNT5A, WNT4 or WNT3A also bound to LRR-WSC ( Supplementary Fig. 1 ). WNT5A and WNT4 bound also to the LDL-A domain of PKD1 ( Supplementary Fig. 1b-e) . The affinity of WNT3A to soluble FZD8-CRD is 3.6 ± 1.2 nM (ref. 24) . Thus, using the FZD8-CRD/WNT9B and FZD8-CRD/WNT3A interactions as 'affinity rulers' , we deduced that the PKD1/WNT9B or PKD1/WNT3A interactions were of comparable affinity to that of FZD8/WNT3A. Therefore, PKD1 can interact with WNTs that function through β-catenin (WNT3A), independently of β-catenin (WNT5A), or both (WNT9B, WNT4), with an estimated affinity in the low nanomolar range. (Fig. 2b,c) . These data indicated that PKD1 and TRPP2 mediated WNT9B-induced Ca 2+ influx rather than Ca 2+ release from intracellular stores. WNT9B-induced whole-cell currents were determined in 50 nM intracellular Ca 2+ using the whole-cell configuration of the patch clamp technique. Addition of WNT9B (500 ng ml −1 ) induced large currents in cells co-transfected with wild-type PKD1 and TRPP2 (Fig. 2d,e) . These currents were ∼50-100-fold larger than PKD1/TRPP2 currents reported earlier 19, 25, 26 . Cells co-transfected with the pathogenic PKD1 S99I (ref. 27 ) and TRPP2 failed to respond to WNT9B (Fig. 2f,i,l) , although PKD1 S99I was expressed at comparable levels to wild-type PKD1 (Supplementary Figs 2a and 3a) . Cell surface biotinylation revealed that S99I severely compromised surface expression of PKD1 S99I ( Supplementary Fig. 2b ). However, cell surface expression of TRPP2 was unaffected ( Supplementary Fig. 2c ). Consistently, cell surface expression of TRPP2 was unchanged in wild-type and Pkd1-null mouse embryonic fibroblasts (MEFs; Supplementary Fig. 2d ). These data suggested that cell surface expression of PKD1 is required for WNT9B-induced currents.
WNT9B activates heterologously expressed PKD1/TRPP2 complex
As at 50 nM of intracellular Ca 2+ other Ca 2+ -activated channels could contribute to whole-cell currents, we buffered intracellular Ca 2+ with 10 mM EGTA to eliminate contribution of these endogenous channels. However, while the contribution of endogenous channels is suppressed in zero intracellular Ca 2+ , the activity of TRPP2 is also suppressed by 80-90% 28 . As expected, in zero intracellular Ca 2+ , WNT9B-induced PKD1/TRPP2-dependent currents were ∼10-fold smaller than currents in 50 nM of intracellular Ca 2+ and showed strong outward rectification, which is typical for members of the polycystin family of ion channels 21, 29, 30 ( Fig. 3b,h ). The reversal potential was near −20 mV, consistent with the much higher K + permeability of TRPP2 compared with Na + or Ca 2+ (ref. 31, 32) . Coexpression with PKD1 S99I did not result in WNT9B-induced currents (Fig. 3c,h ), as shown earlier (Fig. 2f) . Co-transfection of PKD1 and the TRPP2 pathogenic mutant, TRPP2 D511V , suppressed the WNT9B response by ∼75% compared with wild-type TRPP2 (Fig. 3d,h ). Cells co-transfected with PKD1 and pathogenic TRPP2
R872X that does not interact with PKD1 failed to respond (Fig. 3e,h ), indicating that the PKD1/TRPP2 interaction is required for the WNT9B response. Replacement of the pore-forming region of TRPP2 with the equivalent region of the K + -permeable Kv1.3 (TRPP2 Kv1.3 ) suppressed inward currents but not outward currents carried by K + (Fig. 3f,h ). The chimaeric TRPP2
Kv1.3 channel was expressed in comparable levels to wild-type TRPP2 and maintained its interactions with wild-type TRPP2 or PKD1 ( Supplementary Fig. 3c,d ). These data suggested that TRPP2 directly contributed to the formation of WNT9B-induced currents and the interaction with PKD1 was required for the effect. PKD1L1 physically interacts with TRPP2 33, 34 . However, PKD1L1 did not interact with WNT9B (Fig. 1b) . Consistently, it did not form a WNT9B-inducible channel complex in CHO-K1 cells (Fig. 3g,h ). Overall, results from these experiments support the hypothesis that the PKD1/TRPP2 complex was activated by WNT9B, probably through a direct ligand-receptor interaction between WNT9B and PKD1. To test whether activation of the PKD1/TRPP2 channel involves activation of endogenous FZDs, we co-expressed ZNRF3 and tested for an effect on WNT9B-induced currents. ZNRF3 functions as an E3 ubiquitin ligase clearing FZDs from the cell surface 35 . ZNRF3 robustly suppressed WNT3A-induced activation of the canonical Wnt/β-catenin pathway, which requires FZDs ( Supplementary Fig. 3b ), but had no effect on WNT9B-induced currents (Fig. 3h) . These data suggested that PKD1/TRPP2 functioned independently of FZDs in CHO-K1 cells.
To further strengthen the evidence of FZD-independent activation of TRPP2, we co-transfected PKD1 and TRPP2 into Drosophila S2 cells, which lack FZDs 36 . First, we showed that purified WNT9B bound to the cell surface of S2 cells transiently transfected with PKD1 and TRPP2 ( Supplementary Fig. 4a,b) . The pattern of cell surfacebound WNT9B was 'spotty' suggesting that PKD1/TRPP2 channels are not uniformly distributed at the cell surface, as has been shown for Drosophila Fzd2 36 . Next, we showed that WNT9B (500 ng ml −1 ) induced whole-cell currents only in transfected cells ( Supplementary  Fig. 4c ), providing additional evidence for FZD-independent WNTinduced activation of PKD1/TRPP2.
TRPP2 mediates WNT-induced whole-cell currents in MEFs
Wild-type MEFs express PKD1 11 and TRPP2 (Fig. 6a,b and Supplementary Fig. 2d ) and deletion of Pkd2 is expected to cause an upregulation of the Wnt/β-catenin pathway and constitutive activation of p38-MAPK 37 . Consistently, phospho-β-catenin levels were slightly decreased, whereas phospho-p38-MAPK levels were slightly increased in Pkd2-null MEFs ( Supplementary Fig. 5b,c) . WNT3A induced activation of the canonical Wnt/β-catenin pathway S99I /TRPP2-co-transfected CHO-K1 cells (f,i,l) in 50 nM intracellular Ca 2+ concentration. La 3+ (100 µM) was added at the indicated times. I-V curves were taken before (black) and 5 min after (red) the addition of WNT9B in the bath solution of untransfected (j, n = 6 cells pooled from two independent experiments), PKD1/TRPP2-(k, n = 12 cells pooled from four independent experiments) or PKD1 S99I /TRPP2-co-transfected CHO-K1 cells (l, n = 6 cells pooled from four independent experiments). Representative time courses (d-f) and step currents (g-i) from 6 (untransfected), 12 (PKD1+TRPP2) or 6 (PKD1 S99I +TRPP2) cells. All statistical tests were performed using paired Student's t-test, * * P < 0.01. Data are shown as mean ± s.e.m.
in Pkd2 mutant cells and this increase was 2-3-fold higher compared with wild-type cells ( Supplementary Fig. 5g ). Overexpression of ZNRF3 suppressed this effect ( Supplementary Fig. 5h ). Expression levels of Fzd1/2/6/7/8, and Ryk messenger RNAs or LRP6 and ROR2
proteins (LRP5 and ROR1 are not expressed in MEFs) were not different between wild-type and Pkd2-null MEFs ( Supplementary  Fig. 5a ,e,f). The expression level of DVL1 or DVL2 was similar between Pkd2
+/+ and Pkd2 −/− cells, but slightly reduced in Pkd1 ) * * * * * * * * * * * * * * * * * * PKD1+TRPP2 PKD1 S99I +TRPP2 PKD1+TRPP2 Kv1.3 * * * * * PKD1+TRPP2 D511V * * PKD1+TRPP2 R872X * PKD1L1+TRPP2 U n t r a n s f e c t e d P K D 1 (a-h) I-V curves taken before (black) and 5 min after (red) the addition of WNT9B (500 ng ml −1 ) in the bath solution of untransfected (a, n = 5 cells pooled from two independent experiments), PKD1/TRPP2-(b, n = 8 cells from three independent experiments), PKD1 S99I /TRPP2-(c, n = 7 cells from three independent experiments), PKD1/TRPP2 D511V -(d, n = 11 from four independent experiments), PKD1/TRPP2 R872X -(e, n = 7 cells from three independent experiments), PKD1/TRPP2 Kv1.3 -(f, n = 12 cells from five independent transfections), PKD1L1/TRPP2-(g, n = 9 cells from five independent experiments) or PKD1/TRPP2/ZNRF3-(h, n = 11 cells pooled from three independent transfections) co-transfected CHO-K1 cells in zero intracellular Ca 2+ . (i) Summary data of inward (−100 mV) or outward currents (+100 mV) from all groups. Differences between current densities before and after WNT9B for any given membrane potential in I-V curves were determined using paired Student's t-test, * P < 0.05, * * P < 0.01. Data are shown as mean ± s.e.m. Fig. 5d ). In sum, Pkd2-null cells showed higher activation of the canonical Wnt/β-catenin pathway compared with wild-type cells and no obvious differences in the expression levels of FZDs, ROR2, LRP6 and RYK receptors.
cells (Supplementary
When intracellular Ca 2+ was clamped at 50 nM, WNT9B induced large currents in wild-type (Fig. 4a , black filled squares; Fig. 4c , red filled squares), but not Pkd2-null cells (Fig. 4a,c , blue open circles). WNT9B-induced currents showed a reversal potential at 0 mV and were reversibly blocked by La 3+ , as was seen in CHO-K1 cells transfected with PKD1 and TRPP2 (Fig. 2e,h ). In zero intracellular Ca 2+ , WNT9B-induced whole-cell currents showed outward rectification and a reversal potential close to −20 mV ( Fig. 4d-f) , as was seen in CHO-K1 cells transfected with PKD1 and TRPP2 under the same conditions (Fig. 3b) . WNT9B did not induce a significant current in Pkd2 −/− cells (Fig. 4d,f , blue open circles). Therefore, these experiments demonstrated that WNT9B was able to Step currents are shown 5 min after the addition of WNT9B (500 ng ml −1 ) in the bath solution. I-V curves were taken before (black) and 5 min after the addition of WNT9B (red). Differences between current densities before and after WNT9B for any given membrane potential in I-V curves were determined using paired Student's t-test, * P < 0.05, * * P < 0.01. Data are shown as mean ± s.e.m. Representative images of time courses (a,d,g,j,m) and step currents (b,e,h,k,n) were obtained from 7, 6, 12, 5 and 12 cells, respectively. (a-i) Time course, step currents and I-V curves of WNT3A-induced wholecell currents in zero intracellular Ca 2+ in mock-(a-c, n=16 cells pooled from six independent experiments) or ZNRF3-transfected Pkd2 +/+ (d-f, n = 20 cells pooled from seven independent experiments), and Pkd2 −/− MEFs (g-i, n = 9 cells from four independent experiments) before (black) and after (red) the addition of WNT3A (500 ng ml −1 ) in the bath solution.
Step currents are shown at 5 min after the addition of WNT9B in the bath solution. Statistical analysis was performed using paired Student's t-test, * P < 0.05, * * P < 0.01. Data are shown as mean ± s.e.m. Representative images of time courses (a,d,g) and step currents (b,e,h) were obtained from 16, 20, 9 cells, respectively.
induce a similar current in native MEFs or CHO-K1 cells transfected only with PKD1/TRPP2, but not in Pkd2-null MEFs. The differential effect of WNT9B in wild-type and Pkd2-null cells was specific, because both cell types responded similarly to extracellular ATP ( Supplementary Fig. 6a-f ). Adding back wild-type TRPP2 in mutant cells restored WNT9B-induced currents ( Fig. 4g-i) , whereas adding back TRPP2
Kv1.3 restored only outward currents, but not inward currents (Fig. 4j-l) , indicating that TRPP2 was directly involved in WNT9B-induced currents. Overexpression of ZNRF3 did not have an effect on WNT9B-induced currents (Fig. 4m-o) indicating that WNT9B-induced TRPP2-mediated currents were independent of FZDs and/or LRP6, as shown in CHO-K1 and Drosophila S2 cells.
Binding experiments showed that WNT3A was able to interact with the LRR-WSC domain of PKD1 (Supplementary Fig. 1 ). However, canonical WNT3A was not expected to induce Ca 2+ signalling. At zero intracellular Ca 2+ , WNT3A induced whole-cell currents in wildtype cells (Fig. 5a-c ), but with a noticeable delay (by about a minute) compared with WNT9B-induced currents (Fig. 4a,g ). Expression of ZNRF3 did not have significant effects on current amplitude, whereas WNT3A failed to induce whole-cell currents in Pkd2-null cells (Fig. 5g-i ).
PKD1 interacts with DVL1 and DVL2, but DVLs do not affect WNT9B-induced PKD1/TRPP2-mediated currents Next, we tested whether PKD1 could physically interact with DVL1 and DVL2 (DVL3 is not present in these cells, as determined by real-time PCR (rtPCR)). We found that DVL1 and DVL2 coimmunoprecipitated with PKD1 in wild-type or Pkd2-null MEFs I g G a n t i -P K D 1 IP Input I g G a n t i -P K D 1 )   75   100   250   100  75  100  75 37 of wild-type MEFs transiently transfected with a DVL2-specific siRNA (n = 18 cells pooled from five independent experiments) or a mixture of DVL1 and DVL2 siRNAs (n = 13 cells pooled from four independent experiments). Statistical tests were performed using paired Student's t-test, * * P < 0.01. Data are shown as mean ± s.e.m. (e) Knockdown efficiency of DVL1 and DVL2 siRNAs. Wild-type MEFs were transiently transfected with the indicated siRNAs, and cell lysates were immunoblotted with anti-DVL1, anti-DVL2 or anti-β-actin. The experiment was performed once. Unprocessed original scans of blots are shown in Supplementary Fig. 8 . (Fig. 6a,b) . Deletion analysis showed that DVL2 interacted with PKD1 and the interaction was abrogated by the E499G mutation in DVL2 38 . This mutation is located within the Dishevelled, Egl-10 and Pleckstrin (DEP) domain (Fig. 6c) , known to mediate the effects of DVL2 on PCP 39, 40 . It also impairs phosphorylation of DVL2 38 . Nevertheless, depletion of DVL2 or both DVL1 and DVL2 using RNAi (Fig. 6e) did not show a significant effect on WNT9B-induced whole-cell currents (Fig. 6d) , suggesting that although DVL1/2 physically interact with PKD1, they are not required for the formation of a functional PKD1/TRPP2 channel complex.
WNT9B-induced cell migration is dependent on TRPP2
WNT5A was shown to promote directional cell migration in a variety of cell types through a process involving both localized Ca 2+ release transients originating from the cortical endoplasmic reticulum and Ca 2+ influx 7 . Both types of Ca 2+ signalling were required for directional cell migration through the formation of the WNT5A-mediated receptor-actin-myosin polarity structure in the trailing edge of a migrating cell 7 . Thus, we tested whether WNT9B could induce Ca 2+ release. WNT9B did not induce Ca 2+ release in wildtype or Pkd2-null MEFs, in contrast to ATP, which elicited a similar response ( Supplementary Fig. 6g,h ). Next, we tested whether WNT9B could promote directional cell migration in wild-type and Pkd2-null MEFs, through TRPP2 and an increase in intracellular Ca 2+ concentration. Wild-type or Pkd2-null cells were stimulated with WNT9B for up to 2 h and the number of cells with a typical migratory phenotype (Fig. 7a) was determined in both cultures by double staining for F-actin and myosin IIB. WNT9B failed to induce this migratory phenotype in Pkd2-null cells, whereas it had a strong effect on wild-type cells (Fig. 7a,b) . To test whether WNT9B-induced cell polarization was dependent on intracellular Ca 2+ , Pkd2
MEFs were pretreated with dimethylsulphoxide (DMSO) or 10 µM BAPTA/AM for 45 min before adding WNT9B. BAPTA/AM blocked WNT9B-induced cell polarization (Fig. 7c) to a degree similar to Pkd2-null cells (Fig. 7b) . To test whether Pkd2-null MEFs failed to polarize because of TRPP2, we added back wild-type TRPP2 or TRPP2 Kv1.3 . Wild-type TRPP2, but not TRPP2 Kv1.3 rescued cell polarization in Pkd2 −/− MEFs (Fig. 7d,e) . Consistently, Pkd2-null cells failed to migrate towards a WNT9B gradient using a chemokinetic assay (Fig. 7f,g ). In contrast to WNT9B, Pkd2 −/− fibroblasts migrated normally in response to PDGF-BB (25 ng ml −1 ; Fig. 7h ), a strong chemokinetic factor acting through Ca 2+ flickers 41 , store-, and/or receptor-activated Ca 2+ channels 42 , indicating that WNT9B-activated PKD1/TRPP2-mediated currents were distinct from the channels activated by PDGF-BB. Overall, these experiments showed that cells lacking TRPP2 exhibited reduced directional migration, suggesting that one of the functions of WNT9B-induced activated TRPP2 in cell culture is to establish polarization during directional cell migration.
pkd1 cooperates with dvl2 to maintain normal kidney tubulogenesis in Xenopus embryos Next, we used Xenopus as a model organism 43, 44 to test whether pkd1 could function within the Wnt pathway. We chose dvl2 to experimentally downregulate Wnt signalling, because dvl2 is the main isoform expressed in the Xenopus pronephric kidney 45 . Knockdown of pkd1 using two independent splicing morpholinos (sMOs), one described in ref. 46 (Pkd1-sMO1) and another one (Pkd1-sMO2) described here ( Supplementary Fig. 7 ), resulted in oedema and dysplastic (dilated and shortened) pronephric tubules (Fig. 8i,l) . Knockdown of dvl2 resulted in a cystic kidney phenotype grossly similar to pkd1 knockdown (Fig. 8i,l) . Importantly, this phenotype could be reversed by co-injection of human DVL2 mRNA, but not DVL2-E499G mRNA, which does not interact with PKD1 (Fig. 8m) . Next, we combined a suboptimal dose of the Pkd1-sMO1, which by itself did not cause any cystic phenotype, with decreasing amounts of Dvl2-MO (Fig. 8a-i,l) . The combined knockdown resulted in a synergistic effect compared with the individual MOs, suggesting a functional interaction between pkd1 and dvl2. Finally, injection of an MO targeting wnt9a (Wnt9A-MO), one of the WNT ligands specifically expressed in the pronephric kidney 43 , on its own did not cause oedema formation or dysplastic kidneys (Fig. 8j) . However, combining Wnt9-MO with a suboptimal dose of Pkd1-sMO1 demonstrated synergism (Fig. 8j-l ) similar to the one observed for Dvl2-MO and Pkd1-sMO1. Together these data support the hypothesis that wnt9a, pkd1 and dvl2 function in the same pathway in pronephric development.
DISCUSSION
Our data provide evidence that the PKD1/TRPP2 channel complex can function as a ligand-activated channel. Our data support the possibility of a direct ligand/receptor interaction for several reasons. First, the PKD1/WNT interaction does not require cell surface receptors, as it can occur in the extracellular space in trans and also, using purified proteins. Second, PKD1 is unlikely to function as a FZD or RYK co-receptor or downstream of these receptors, because neither WNT9B nor PKD1/TRPP2 induced or mediated Ca 2+ release from the endoplasmic reticulum, an effect associated with FZD or RYK receptor activation 4, 6, 8 . Third, clearing FZDs and LRP6 from the cell surface did not suppress WNT9B-or WNT3A-induced currents and heterologous expression of PKD1 and TRPP2 in Drosophila S2 cells, which lack endogenous FZD receptors, supported WNT9B-induced currents. Therefore, PKD1 is likely to function as a (co)receptor for WNT ligands to induce Ca 2+ influx, independently of FZD receptors. The fact that WNT3A activated TRPP2, a Ca 2+ permeable channel, suggests that WNT ligands could induce Ca 2+ influx regardless of their ability to signal through β-catenin as long as they can bind to PKD1 and PKD1/TRPP2 is present in the target cell. This may represent a general property of WNTs and implies a broader effect of WNTs on Ca 2+ signalling than previously thought. It may also help explain the strong influence of cell context on WNT signalling.
We show that TRPP2 plays an important role in directional cell migration of MEFs in response to WNT9B. This is consistent with recent studies showing an essential role of PKD1 and TRPP2 in directional cell migration in embryonic kidney and endothelial cells during lymphatic development 11, 47, 48 . Despite caveats, directed cell migration in cell culture has been used as a reliable surrogate assay for convergent extension during embryonic development 11 . Defective convergent extension was proposed to underlie cystogenesis in embryonic Pkd1 and Wnt9b mutant kidneys 10, 11 . Although our data do not contradict this idea, we do not believe that defective convergent extension is the sole cause of cystogenesis in ADPKD, as deletion of core components of PCP, such as Vangl2, shows very mild cystic dilatation 49 . We rather propose that defective WNT-induced PKD1/TRPP2-mediated Ca 2+ signalling can adversely affect multiple processes, including convergent extension. Such a combinatorial effect can contribute to cyst initiation/formation. Experiments in Xenopus embryos suggest that pkd1 genetically interacts with dvl2 in pronephric development. Overexpression of a dexamethasone-inducible, PCP-specific dominant-negative form of dvl2 in Xenopus embryos produces dilated and shortened tubules 50 , the same phenotype as the one modified by the combinatorial effects of pkd1 and dvl2. We also show that PKD1 physically interacts with DVL2 and a point mutation in the DEP domain of DVL2 renders it unable to interact with PKD1. However, DVLs are dispensable for WNT9B-induced channel activity. These data suggest that DVL proteins can function as downstream effectors of PKD1/TRPP2 in the embryonic kidney. DVLs have been shown to function downstream of Wnt/Ca 2+ signalling by an unknown mechanism 8, 51 . One possibility is that the physical interaction between PKD1 and DVLs may function to keep the two proteins in close proximity so that incoming Ca 2+ could directly impinge on DVLs or immediate downstream effectors.
We show that several WNTs can bind to PKD1. These data suggest that PKD1/TRPP2 can mediate effects of other WNTs not only in the kidney but in other tissues where WNT/Ca 2+ activity is present. This is supported by the ubiquitous expression of PKD1 and TRPP2 and the wider phenotypic spectrum caused by the homozygous deletions of Pkd1 or Pkd2 genes compared with the phenotypic spectrum of patients with ADPKD. We speculate that renal (cystogenesis), cardiovascular (heterotaxy, defective septation, lymphatic development) 47, 48, [52] [53] [54] , hearing (inner ear architecture) 55 , hydrocephalus 56, 57 and skeletal defects (neural crest cell migration, spina bifida, osteoblast differentiation) [58] [59] [60] in Pkd1-or Pkd2-null mice may represent bona fide defects of the Wnt/Ca 2+ signalling pathway.
METHODS
Methods and any associated references are available in the online version of the paper. 
org). Drosophila
Schneider S2 cells were purchased from Invitrogen. The HEK293 cell line has been misidentified according to ICLAC, but it was only used here to overexpress PKD1 fragments as Fc fusions and Myc-tagged WNT5A owing to its high transfectability. All cells lines were tested and found to be negative for mycoplasma using PCR and DAPI staining. HEK293 or HEK293T cells were maintained in DMEM supplemented with 10% FBS. CHO-K1 were grown in Ham's F-12/DMEM with 10% FBS. Pkd1 −/− and Pkd2 −/− mouse embryonic fibroblasts (MEFs) and wild-type littermate type control cells were cultured in DMEM supplemented with 10% heat-inactivated FBS, 1% non-essential amino acids, and 1% penicillin-streptomycin.
Reagents. Purified WNT9B and WNT3A were purchased in a carrier-free formulation from R&D.
Transfections. CHO-K1 cells were transfected by Lipofectamine 2000 (Invitrogen) according to the manufacturer's recommendations. HEK293T cells were transfected with the calcium phosphate precipitation method. MEFs were transfected by nucleofection (Lonza), according to the manufacturer's recommendations. In a typical transfection reaction, 2 × 10 6 wild-type MEFs were transfected with 0.2 µg CD8α and 20 pm (20 µM) of siRNAs or 1.8 µg of plasmid DNA (that is, wild-type TRPP2) using Nucleofector (Program T-20, MEF Kit 2, Lonza).
Immunoprecipitations.
In experiments where immunoprecipitations were performed in lysates, cells were lysed in 1% Triton X-100, 150 mM NaCl, 10 mM Tris-HCl at pH 7.5, 1 mM EDTA, 1 mM EGTA, 0.5% NP-40, and 10% sucrose with protease inhibitor cocktail (Roche Applied Science) at 4 • C for 30 min and lysates were collected by centrifugation (18,000g , 20 min). In immunoprecipitations using cultured media, media were collected and filtered (Millipore). Lysates (500 µl) or filtered media (1 ml) were incubated at 4 • C overnight with the indicated antibodies listed in Supplementary Table 1 coupled to Sepharose beads. Beads were pelleted by centrifugation, and pellets were washed in lysis buffer three times for 20 min with rotation at 4 • C. Immunoprecipitated proteins immunoblotted with indicated antibodies as listed in Supplementary Table 1. siRNAs. The siRNAs used in this study are listed in Supplementary Table 2.
Plasmids. Expression plasmids carrying human WNT9B and Flag-PKD1L1 cDNAs were purchased from Origene. WNT3A, WNT4, WNT5A and mouse TRPP2 plasmids were obtained from Open Biosystems (Thermo). The mouse FZD8-CRD-Fc construct was obtained from Addgene. Flag-tagged mouse PKD1 and human HA-tagged PKD1 were provided by J. Yang (Columbia University) and F. Qian (University of Maryland), respectively. ZNRF3 was obtained from F. Cong (Novartis). Human TRPP2 D511V and TRPP2 R872X , and mutant forms of mouse LRR-Fc and human full-length PKD1 were generated using the QuikChange mutagenesis kit according to the manufacturer's instructions (Stratagene). The LRR-WSC domain of mouse PKD1 (amino acid residues 24-255), LDL-A domain of mouse PKD1 (amino acid residues 397-671), and first PKD domain of human PKD1 (amino acid residues 282-353) were cloned into the pAP3 vector 61 that contained the signal sequence of K-cadherin fused to the alkaline phosphatase cDNA. The thermostable placental alkaline phosphatase cDNA was replaced with the CH 2 -CH 3 region of human IgG (Fc) to generate LRR-WSC-Fc, LDL-A-Fc and hPKD1(d1)-Fc constructs, respectively. TRPP2
Kv1.3 was made by replacing the extracellular loop connecting transmembrane segments 5 and 6, from amino acid residue 617 to 665 of human TRPP2 (NP_000288) with the equivalent loop of mouse Kv1.3 (NP_032444) from amino acid residue 366 to 448. 3xFlag-tagged DVL2, DVL2-dPY, DVL2-dDIX and DVL2-E499G were gifts from J. Wrana (LunenfeldTanenbaum Research Institute, Canada) (Addgene plasmid nos: 24802, 24808, 24805 and 24803, respectively) and TRPP2-Myc (or M-PKD2) was a gift from G. Germino (NIH/NIDDK, USA) (Addgene plasmid no. 21370).
Protein-protein interactions using purified proteins. The LRR-WSC domain of PKD1 fused to human IgG (LRR-WSC-Fc) was stably transfected into HEK293 cells. Five 10-cm dishes containing confluent cultures of HEK293/LRR-WSC-Fc cells were conditioned for 4 days in Optimem. LRR-WSC-Fc was captured using protein G and beads were washed ten times (20 min each) with immunoprecipitation solution where the NaCl concentration was adjusted to 1 M to minimize interaction with proteins present in the extracellular solution. After the final wash, beads were reconstituted in normal immunoprecipitation solution (150 mM NaCl) and incubated with 500 ng of purified WNT9B in 0.05% BSA in 1 ml total volume overnight at 4 • C. Unbound WNT9B was removed by four 20-min washes at 4 • C. Bound WNT9B was detected by immunoblotting using goat anti-WNT9B. To determine direct binding of WNT9B to TRPP2, six 10-cm dishes of HEK293T cells were transiently transfected with a Myc-tagged form of human TRPP2. Myctagged TRPP2 was pulled down using anti-Myc and washed 10 times (20 min each) in normal immunoprecipitation solution (150 mM NaCl). Beads containing Myc-TRPP2 were incubated with 500 ng of purified WNT9B in 0.05% BSA in 1 ml immunoprecipitation solution overnight at 4 • C. Beads were washed four times (20 min each) with immunoprecipitation solution to remove unbound WNT9B. Bound WNT9B was detected by immunoblotting using goat anti-WNT9B. Protein quantification was carried out by the LI-COR Odyssey Fc imaging system.
Ratiometric single-cell Ca
2+ imaging. CHO-K1 cells were plated onto glass coverslips and placed in 35-mm dishes where they were transfected with fulllength mouse PKD1, TRPP2 and yellow fluorescent protein (YFP) cDNAs using Lipofectamine 2000 (Invitrogen). Twenty-four hours after transfection cells were loaded with 2 µM Fura-2/AM in extracellular solution (ECS) containing 140 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1. Pkd2 +/+ and Pkd2 −/− MEFs were plated onto glass coverslips. Twenty-four hours after seeding, cells were loaded with 2 µM Fura-2/AM in Ca 2+ -free extracellular solution (same as ECS but without CaCl 2 plus 10 µM EGTA) in the presence of 0.05% Pluronic F-127 for 45 min at room temperature. Cells were washed twice in ECSCa 2+ -free and incubated for 15 min at 37 • C before intracellular imaging. Coverslips were mounted onto the stage of an Axiovert200 inverted microscope and cells were treated with 500 ng ml −1 WNT9B followed by 100 µm ATP at the end of experiment. Cells (47 for Pkd2 +/+ , 37 for Pkd2 −/− ) were imaged using a Fura-2 filter set with a scientific CMOS camera (Pco. Electrophysiology. Immediately before each experiment, a coverslip bearing CHO-K1 or MEFs was removed from the culture plate and placed onto a recording chamber, which was mounted on the stage of a Nikon Diaphot inverted microscope. The extracellular solution was normal Tyrode solution containing (in mM): 135 NaCl, 5.4 KCl, 0.33 NaH 2 PO 4 , 1 MgCl 2 , 1.8 CaCl 2 , 5 HEPES, 5.5 glucose (pH 7.4). Pipettes were made from capillary glass (plain; Fisher Scientific) with a micropipette puller and polisher (PP-830 and MF-830, respectively; Narishige, Tokyo, Japan). They were back-filled with internal solution composed of (in mM): 100 K-aspartate, 30 KCl, 0.3 Mg-ATP, 10 HEPES, 10 EGTA, and 0.03 GTP (pH 7.2). In experiments where intracellular Ca 2+ was clamped to 50 nM, 4 mM CaCl 2 was added to the internal solution. The pipette resistance varied from 3 to 5 M when filled with the internal solution. Offset potential was corrected just before a gigaohm seal formation. Series resistance and capacitance transients were compensated when CHO-K1 cells were used with a Warner PC-505B amplifier (Warner Instrument) and pClamp 10.0 software (Axon Instrument). Cell capacitance was not compensated in MEFs owing to their large size (>100 pF). Currents were digitized with a Digidata 1440A converter (Molecular Devices), filtered through an internal four-pole Bessel filter at 1 kHz, and sampled at 2 kHz. Inward and outward whole-cell currents were obtained by employing a step-pulse protocol from −100 to +100 mV every 5 s for 200 ms duration from a holding potential of −60 mV. I -V curves were taken before and 5 min after the addition of WNT9B or WNT3A in the bath solution and derived from a step protocol ranging from −100 to +100 mV with 20 mV increments for 200 ms duration from a holding potential of −60 mV. Steady-state currents towards the end of the pulse (between 50 and 100 ms) were used in I -V curves. Cells with a similar diameter exhibiting stable baseline currents of similar magnitude among various groups were selected for recordings and used for further analysis. WNT9B or WNT3A stock solution (100 ng µl) was dissolved in Tyrode solution and added directly to the recording chamber. Current traces were analysed off-line with pClamp 10.0.
Indirect immunofluorescence.
MEFs were seeded on poly-L-lysine-coated glass coverslips (8×10 4 cells per coverslip on a 6-well plate) for 24 h, washed and starved for 18 h. WNT9B (500 ng ml −1 ) was added at time 0 and cells were incubated at 37 • C for 30, 60 and 120 min. Cells were fixed in 10% formalin solution (SigmaAldrich) at room temperature, permeabilized with 0.2 % Triton X-100 in PBS, blocked in 5% BSA, 0.1% Tween/Tris-buffered saline and incubated with rabbit anti-myosin II B (Sigma-Aldrich, 1:200) in blocking buffer at room temperature for 1 h. Cells were washed with PBS and incubated with donkey anti-rabbit Alexa 568 secondary antibody (Molecular Probes, 1:2,000) and phalloidin coupled to Alexa 488 (Molecular Probes, 1:40) for 1 h at room temperature. DNA was stained with 5 µg ml −1 DAPI for 10 min. Coverslips were mounted with ProLong (Molecular Probes), and cells were imaged using an Olympus IX81 inverted confocal microscope. Images were analysed by the Olympus Fluoview software.
Rescue experiments. Two million Pkd2 −/− cells were transfected with GFP+pCDNA3 (mock), GFP+wild-type TRPP2 (TRPP2 WT ) or GFP+TRPP2 Kv1.3 expression plasmids using nucleofection. Transfection efficiency was 20-30% as determined by GFP. Eighteen hours following transfection, cells were seeded on poly-L-lysine-coated coverslips, serum-starved for 18 h, and stimulated with purified WNT9B (500 ng ml −1 ) or PBS for 1 h. Cells were fixed and double-stained with phalloidin-Texas Red and anti-myosin II B as described above. Twenty-six to thirty-nine confocal images containing 4-12 GFP-positive cells were randomly collected from each group and the number of GFP-positive migrating cells per field was recorded. The total number of cells scored per group was 366 (pcDNA3), 352 (TRPP2 WT ) and 390 (TRPP2 Kv1.3 ). Three independent transfections (experiments) using identical conditions (except for cell passage number) were performed with similar results.
Chemokinetic assay. After serum starvation for 18 h, Pkd2 +/+ or Pkd2 −/− MEFs (5×10 4 per insert) were seeded in inserts (8 µm in pore size, BD Biosciences), which were placed in 24-well dishes containing 500 µl of media supplemented with 0.1% FBS and PBS, WNT9B (1 µg ml −1 ) or PDGF-BB (25 ng ml −1 ). Cells were allowed to migrate through inserts for 6 h at 37 • C. Cells in the lower side of inserts facing the bottom of the well were fixed with methanol, stained with haematoxylin and eosin, and counted. Quantification of migrating Pkd2 +/+ or Pkd2 −/− cells was obtained from three independent experiments performed in sextuplicates (WNT9B) or quadruplicates (PDGF-BB).
Functional expression of PKD1 and TRPP2 in Drosophila S2 cells. For molecular cloning and expression, the Bgl2-Age1 fragment encompassing ∼13 kb of human PKD1 cDNA was moved from HA-PKD1 (HBF307N-hPKD1) to the Drosophila pMT/V5-HisA vector (Invitrogen). The remaining 5 part of the cDNA was amplified by PCR incorporating the Drosophila optimal translational initiation start site (CAAA) immediately upstream of the first methionine and was cloned into pMT/V5-HisA upstream of the Bgl2-Age1 fragment of human PKD1 using EcoR1 (5 ) and Bgl2 (3 ). The EcoR1-Bgl2 fragment of PKD1 in pMT/V5-HisA was verified by complete sequencing. Mouse TRPP2 bearing the CAAA sequence upstream of its first methionine was cloned into the pMT/V5-HisA vector as an EcoR1-Xho1 fragment. The human CD8α cDNA excluding the nucleotide sequence corresponding to the signal peptide was cloned into the pMT/Bip/V5-HisA vector as a Kpn1-EcoR1 fragment. CD8α or PKD1+TRPP2 in pMT/BIP or pMT vectors was transiently transfected into Drosophila S2 cells using nucleofection (Program G-30, transfection kit V, Amaxa). Transfection was carried out in 12-well plates containing 2 × 10 6 (for functional expression) or 10 7 cells (for biochemical expression) using 2 µg of total DNA (1.5 µg PKD1, 0.3 µg TRPP2, and 0.2 µg CD8α). Transfection efficiency using pMT/GFP was routinely at 80-90%. Cells were treated with 700 µM CuSO 4 24 h following transfection and for 48 h to induce the expression of CD8α, PKD1 and TRPP2.
For electrophysiology, 24 h following induction by CuSO 4 (700 µM), cells were seeded onto poly-L-lysine-coated coverslips and processed for electrophysiology after another 24 h. Whole-cell currents were obtained as described above for MEFs and CHO-KI cells with the following exception: pipette resistance was 6 M when back-filled with intracellular solution where the Ca 2+ concentration was adjusted to 100 nM (physiological). Typical capacitance was 9-11 pF. Extracellular solution was Tyrode solution. Cell capacitance was not compensated.
For WNT9B cell surface binding, cells were seeded onto poly-L-lysine-coated glass discs the day before the experiment. On the day of the experiment, cells were washed twice with PBS and incubated with 1 µg ml −1 purified WNT9B in 0.5% BSA at 4 • C for 3 h. Cells were washed three times (10 min each wash) with cold PBS and fixed in 2% paraformaldehyde in PBS for 15 min at room temperature. Cells were washed three times with cold PBS and incubated overnight with 1:500 dilution (or 0.4 µg ml −1 ) of goat anti-WNT9B in 5% donkey serum in PBS. The next day, cells were washed there times in cold PBS and incubated for 1 h with donkey antigoat conjugated to Alexa 488. After three final washes with cold PBS, coverslips were mounted with ProLong (Molecular Probes), and cells were imaged using an Olympus IX81 inverted confocal microscope (60×). Images were analysed by the Olympus Fluoview software.
TOP/FOP Flash reporter assays. One million MEFs or CHO-K1 cells were transfected with a Super TOP-Flash or FOP-Flash plasmid and Renilla luciferase pRL-TK vector together with pcDNA3 or ZNRF3 expression vector, using the Ingenio Electroporation Kit (Mirus-Bio) and the Nucleofector IIb Device (Lonza). Renilla luciferase was used as the internal control reporter to normalize transfection efficiency. All transfections were performed with 0.5 µg of Super TOP-Flash or FOPFlash, 0.05 µg of pRL-TK, and 2 µg of pCDNA3 or ZNRF3. After 18 h following transfection, cells were split into 18 wells of a 24-well plate. After 24 h, cells were treated with PBS, WNT3A (500 ng ml −1 ), WNT9B (1 µg ml −1 ), or a mixture of WNT3A and WNT9B for another 24 h and lysed in a reporter lysis buffer (Promega). Luciferase assay was performed using the Dual Luciferase Assay System kit according to the manufacturer's protocols (Promega). Relative luciferase activity was reported as fold induction after normalization for transfection efficiency. Three independent experiments were performed in sextuplicates.
RNA isolation and rtPCR. Total RNA from Pkd2 +/+ and Pkd2 −/− MEFs was extracted using Trizol reagent (Invitrogen) according to the manufacturer's instructions. Five micrograms of total RNA was used for cDNA synthesis with a 1:1 mixture of 50 ng µl −1 random hexamers (Invitrogen) and 0.5 µg µl −1 Oligo dT (Invitrogen). rtPCR was performed on the resultant cDNA using the PerfeCTa CYBR Green SuperMix for iQ (Quanta BioSciences) following the manufacturer's instructions. Primer sequence information is presented in Supplementary Table 2 . rtPCR was carried out using a Bio-Rad iCycler Thermal Cycler (Bio-Rad). Reactions were run in triplicate in three independent experiments. The mRNA levels of each target protein were normalized relative to housekeeping gene GAPDH mRNA levels in each sample.
Xenopus embryo manipulations. Xenopus embryos obtained by in vitro fertilization were maintained in 0.1× modified Barth medium 62 and staged according to ref. 63 . The sequences of the antisense morpholino oligomers (GeneTools, LLC) used in this study are listed in Supplementary Table 2 . The efficacy of Dvl2-MO and Pkd1-sMO1 was demonstrated previously 6, 46 . The efficacy of Pkd1-sMO2 was verified by PCR with reverse transcription (RT-PCR) of RNA extracted from stage 35 embryos ( Supplementary Fig. 7e ) using primers spanning exons 17/18 of the predicted Xenopus laevis pkd1 (Xenbase Gene no. 483413, 5 -TGTCCTTGAAG TGCGTGTCA-3 and 5 -CCCGTAGATGTGGTGCTTGA-3 ). In the case of Wnt9A-MO, it was verified using a Wnt9A-GFP fusion construct injected into Xenopus embryos in the presence or absence of the Wnt9A-MO. For morphological scoring of oedema formation, embryos were injected at the 2-to 4-cell stage with the indicated amounts of MO and cultured until sibling embryos reached stage 43. For imaging of the individual pronephric kidneys embryos were injected unilaterally at the 2-cell stage embryo with the indicated amounts of MOs, cultured until stage 40 and fixed in Dent's fixative (4:1 methanol/DMSO). Whole-mount immunofluorescence was performed by incubating the embryos sequentially with 3G8 and 4A6 antibodies 64 and developing them using Alexa Fluor 448-and Alexa Fluor 555-labelled anti-mouse secondary antibodies (Life Technologies). Embryos were analysed individually by confocal microscopy comparing the injected with the contralateral control side. Pronephric kidneys with dilated and shortened nephron segments were classified as dysplastic. In individual cases, three-dimensional reconstruction of the kidneys was used to verify differences in tubule diameter. Analysis was performed in a blinded fashion to avoid bias.
Rescue experiments for the Dvl2-MO were performed by injecting 0.5 µg synthetic mRNA encoding wild-type human DVL2 or mutant DVL2-E499G into a single blastomere at the 2-cell stage followed by injection of 3.2 pmol Dvl2-MO into all four blastomeres at the 4-cell stage. Embryos were cultured until stage 40 and processed for whole-kidney imaging as outlined above. Scoring was based on comparing the kidneys of the Dvl2-MO-injected side to the one of the Dvl2-MO/mRNA-injected side.
Cell surface biotinylation. Wild-type, Pkd1 −/− MEFs, or HEK293T cells cotransfected with TRPP2 and wild-type PKD1 (PKD1 WT ) or PKD1 S99I were washed three times in PBS (pH 8.0), scraped, and re-suspended in 1 ml PBS (pH 8.0). Cell surface proteins were labelled with 1 mM EZ-Link NHS-PEG4-biotin (Thermo Scientific, 21329) for 30 min at room temperature. Biotinylation was terminated by three washes with PBS containing 100 mM glycine, pH 3.0, and lysed in 1% Triton X-100, 150 mM NaCl, 10 mM Tris-HCl at pH 7.5, 1 mM EDTA, 1 mM EGTA, 0.5% NP-40, and 10% sucrose with protease inhibitor cocktail (Roche Applied Science) at 4 • C for 30 min. Lysates were collected by centrifugation (18,000g , 20 min) and biotin-labelled surface proteins were captured on streptavidin-agarose beads at 4 • C by an overnight incubation. Proteins bound to beads were collected by a brief (1 min) centrifugation, and pellets were washed three times with lysis buffer for 20 min at 4 • C. Biotin-labelled surface proteins were eluted with SDS gelloading buffer (50 mM Tris-HCl at pH 6.8, 100 mM dithiothreitol, 2% SDS, 0.1% bromophenol blue, and 10% glycerol) and analysed by western blotting.
Endogenous co-immunoprecipitations. Five 10-cm dishes containing confluent cultures of wild-type MEFs were pooled and lysed in 1 ml of non-denaturing lysis buffer containing 1% Triton X-100, 150 mM NaCl, 10 mM Tris-HCl at pH 7.5, 1 mM EDTA, 1 mM EGTA, 0.5% NP-40 and 10% sucrose with protease inhibitor cocktail (Roche Applied Science) at 4 • C for 30 min. Lysates were cleared by centrifugation (18,000g , 20 min) and incubated with either mouse anti-PKD1 (E4, 5 µg) or mouse IgG (Santa Cruz biotechnology) at 4 • C overnight. Mouse antibodies were captured by Protein G coupled to agarose beads and immunocomplexes were immunoblotted with rabbit anti-Dvl1 (1:200, Thermo Fisher), rabbit anti-Dvl2 (1:1000, Thermo Fisher) or mouse anti-PKD1 (7e12, 1:5,000). Proteins were visualized with an enhanced chemiluminescence detection kit (ECL, Thermo).
Statistics and reproducibility. Student's t-test was used for pairwise comparisons (that is, current amplitudes at defined membrane voltages before and after WNT9B or WNT3A in all I -V curves). One-way ANOVA followed by Newman-Keuls post hoc test was used to analyse data for multiple comparisons. All results are presented as means (±s.e.m.). NS, indicates no significance; * , indicates P < 0.05; * * , indicates P < 0.01; * * * , indicates P < 0.001. No statistical method was used to predetermine sample size. The experiments were not randomized. Evaluations of oedema counts and dysplastic kidneys were performed in a blinded way, so that the person scoring embryos for oedema or dilated and shortened tubules was not aware of the genotype of the animals. For electrophysiology experiments, n indicates the total number of cells per group that were successfully patched and summary data were derived from. One cell is considered to be one biological replicate sample. Cells were pooled across independent experiments as indicated in the figure legends.
